Skip to main navigation Skip to search Skip to main content

Bayer, AskBio announce first patient randomized in GenePHIT phase II trial of AB-1002 to treat congestive heart failure

  • Roger Hajjar,

Press/Media

Period14 Feb 2024

Media coverage

1

Media coverage

  • TitleBayer, AskBio announce first patient randomized in GenePHIT phase II trial of AB-1002 to treat congestive heart failure
    Media name/outletPharmaBiz
    Country/TerritoryIndia
    Date14/02/24
    PersonsRoger Hajjar,